Amygdalin has been demonstrated to stimulate the apoptotic process by upregulating caspase-3 expression and downregulating Bcl-2 expression, as well as inhibiting HepG2 and EAC hepatocellular cancer cell proliferation and upregulating Beclin-1 expression [54]. Here, BECN1 is linked to hepatocellular carcinoma.